May 1, 2008 / Add comment
PR NewsWire
Corgenix Medical Corporation (BULLETIN BOARD: CONX) , a worldwide developer and marketer of diagnostic test kits, has executed a licensing agreement with the Okayama Prefecture Industrial Promotion Foundation covering new diagnostic technology for serum amyloid protein (SAP), an important serum bio-marker for cardiovascular inflammation. The technology was developed by Dr. Eiji Matsuura at the University of Okayama Graduate School of Medicine, Dentistry and Pharmaceutical Sciences.
PR NewsWire
Industrial Minerals Inc. (IMI) - OTCBB: IDSM - (or "the Company") is pleased to announce... Add comment
Newsome's finely tuned report on racial prejudice in the $350-million-a-year NASCAR auto-racing franchise notes the... Add comment
Except for the fact that John Harvey-Jones is British, he might have been called a... Add comment
In 1998, a grass fire near Tracy, California ignited a stockpile of discarded rubber tires... Add comment
Updike's masterful descriptions shine as he reviews a collection of essays about the Museum of... Add comment
Matt Rogatz, a highly-respected real estate broker with more than 20 years of industrial real... Add comment
The organizational structure of Philippine National Police is in the news again after a paid... Add comment
Industrial output fell in February and the New York Fed's manufacturing survey showed business conditions... Add comment
© 2008 Industrial Promotion. All rights reserved. Contact Industrial Promotion. Advertise. Privacy Policy
Leave a Comment About This Article!